Amgen's best chance at breaking into the high-stakes obesity drug market got its start in a basement at the University of Iceland Science Park in Reykjavík, in a freezer chilled to minus-13 degrees Fahrenheit. Bloomberg's Madison Muller explains.…
Anonymous readers can preview up to 1024 characters here. Log in to unlock the full article once ingest succeeds.